Quantcast

Posts related to ‘EPOGEN’

Amgen Set To Run (AMGN, JNJ, BIIB)

Amgen Inc. (NASDAQ:AMGN) is seeing shares trade up another 2% pre-market after yesterday's decision where an FDA panel rejected a proposal to set a specific target for red blood-cell levels ...
Read Full Story »

Amgen: Today’s Review Critical For Anemia Reimbursements (AMGN)

Amgen (NASDAQ:AMGN) has a huge day ahead of it.  The biotech giant is presenting data today on the appropriateuse of Erythropoiesis Stimulating Agents in Chronic RenalFailure patients to a joint ...
Read Full Story »